Efficacy of technology-based interventions in psychosis: a systematic review and network meta-analysis
- Morales-Pillado, Carla 12
- Fernández-Castilla, Belén 3
- Sánchez-Gutiérrez, Teresa 2
- González-Fraile, Eduardo 2
- Barbeito, Sara 2
-
Calvo, Ana
1
-
1
Universidad Complutense de Madrid
info
-
2
Universidad Internacional de La Rioja
info
-
3
Universidad Nacional de Educación a Distancia
info
ISSN: 0033-2917, 1469-8978
Año de publicación: 2022
Volumen: 53
Número: 13
Páginas: 6304-6315
Tipo: Artículo
Otras publicaciones en: Psychological Medicine
Resumen
AbstractBackgroundTechnology-based interventions (TBIs) are a useful approach when attempting to provide therapy to more patients with psychosis.MethodsRandomized controlled trials of outcomes of TBIs v. face-to-face interventions in psychosis were identified in a systematic search conducted in PubMed/Ovid MEDLINE. Data were extracted independently by two researchers, and standardized mean changes were pooled using a three-level model and network meta-analysis.ResultsFifty-eight studies were included. TBIs complementing treatment as usual (TAU) were generally superior to face-to-face interventions (g = 0.16, p ≤ 0.0001) and to specific outcomes, namely, neurocognition (g = 0.13, p ≤ 0.0001), functioning (g = 0.25, p = 0.006), and social cognition (g = 0.32, p ≤ 0.05). Based on the network meta-analysis, the effect of two TBIs differed significantly from zero; these were the TBIs cognitive training for the neurocognitive outcome [g = 0.16; 95% confidence interval (CI) 0.09–0.23] and cognitive behavioral therapy for quality of life (g = 1.27; 95% CI 0.46–2.08). The variables educational level, type of medication, frequency of the intervention, and contact during the intervention moderated the effectiveness of TBIs over face-to-face interventions in neurocognition and symptomatology.ConclusionsTBIs are effective for the management of neurocognition, symptomatology, functioning, social cognition, and quality of life outcomes in patients with psychosis. The results of the network meta-analysis showed the efficacy of some TBIs for neurocognition, symptomatology, and quality of life. Therefore, TBIs should be considered a complement to TAU in patients with psychosis.
Referencias bibliográficas
- 10.1016/j.brat.2010.11.010
- 10.1016/j.nicl.2014.08.026
- 10.1016/j.schres.2012.05.016
- 10.2196/19271
- 10.1007/s11136-011-9944-1
- 10.1186/s12874-015-0060-8
- 10.1176/ps.2006.57.6.822
- 10.1016/j.schres.2012.03.005
- 10.1016/j.schres.2015.01.020
- 10.3758/s13428-012-0261-6
- 10.1093/schbul/sbu155
- Fiszdon, (2020), Schizophrenia Research: Cognition, 19, pp. 100148
- 10.1001/archpsyc.61.9.866
- 10.3389/fpsyg.2015.01450
- 10.1016/j.schres.2018.08.016
- 10.1093/schbul/sby032
- 10.2196/jmir.5250
- 10.1093/schbul/sbu103
- 10.1002/9781119536604
- 10.1016/S2215-0366(20)30307-2
- 10.1016/j.psychres.2020.112780
- 10.3389/fpsyt.2018.00040
- 10.1037/prj0000232
- 10.1016/j.schres.2012.05.009
- 10.2196/mhealth.7088
- 10.4088/JCP.15com10619
- 10.1016/j.schres.2006.09.001
- 10.1176/appi.ajp.2009.09010017
- 10.1016/j.schres.2018.01.012
- 10.1186/1741-7015-11-159
- 10.1023/A:1012953108158
- 10.1037/a0032968
- 10.1016/j.schres.2008.06.026
- 10.1192/bjp.bp.109.066050
- 10.1001/archpsyc.65.7.762
- 10.1080/00220973.2019.1582470
- 10.1007/s10597-005-5077-8
- 10.1093/bmb/ldv017
- Fisher, (2016), Schizophrenia Research: Cognition, 3, pp. 1
- 10.1682/JRRD.2007.02.0032
- 10.1016/S0920-9964(01)00402-9
- 10.1093/schbul/sbs120
- 10.1016/j.jaac.2014.04.004
- 10.1186/2046-4053-4-1
- 10.1136/bmj.38246.594873.7C
- 10.1111/acps.12287
- 10.1002/jrsm.1037
- 10.1093/schbul/sby078
- 10.1177/2045125318781475
- 10.2196/mental.5379
- 10.9781/ijimai.2017.459
- 10.3389/fpsyt.2020.00402
- 10.1093/schbul/sbt232
- 10.1016/j.schres.2019.03.006
- 10.3389/fpsyg.2015.01048
- 10.2196/jmir.6511
- 10.1016/j.jad.2020.12.011
- 10.1016/j.cpr.2017.06.001
- 10.1186/1471-244X-11-73
- 10.2196/jmir.5385
- Shuib, (2019), International Journal of Advanced Science and Technology, 28, pp. 1896
- 10.1111/j.1601-5215.2012.00651.x
- 10.1016/j.jaac.2015.09.018
- 10.1016/j.schres.2013.08.025
- 10.1016/j.rpsm.2020.04.004
- 10.1016/j.psychres.2017.09.031
- 10.3389/fpsyg.2017.02364
- 10.1016/j.biopsych.2010.09.028
- 10.2196/jmir.2851
- 10.3758/s13428-014-0527-2
- 10.1093/schbul/sbi013
- 10.1371/journal.pmed.1002785
- 10.1016/j.psychres.2020.112913
- 10.1016/j.schres.2014.03.021
- 10.2196/16393
- 10.1017/S1355617717001369
- 10.1017/S1352465813000313
- 10.1111/appy.12070
- 10.1016/j.rpsm.2017.01.003
- 10.1176/appi.ajp.2007.07060906
- 10.1016/j.schres.2016.04.033
- 10.1176/appi.ps.201300050
- 10.2196/mental.5324
- 10.1016/j.schres.2005.07.018
- 10.31887/DCNS.2007.9.2/jbobes
- 10.1136/bmj.d5928
- 10.1016/j.jpsychires.2018.11.027
- 10.2196/18848
- 10.1016/j.eurpsy.2015.05.002
- 10.1037/prj0000258
- 10.1093/schbul/sbr165
- 10.1093/schbul/sbv132
- 10.1093/schbul/sbv143
- 10.3102/10769986006002107
- 10.1002/sim.3767
- 10.1093/schbul/sbn170
- 10.2196/10091
- 10.1016/j.schres.2007.07.003
- 10.1176/appi.ajp.2009.08050757
- 10.1007/s40263-013-0047-0
- 10.1371/journal.pone.0210816
- 10.1176/appi.ajp.2017.16121358
- 10.1016/j.schres.2018.06.012
- 10.1080/09602011.2016.1181555
- 10.1176/ps.2009.60.11.1468
- 10.31887/DCNS.2019.21.3/amccleery
- Miley, (2020), Schizophrenia Research: Cognition, 20, pp. 100171
- 10.1016/j.psychres.2008.06.027
- 10.1016/j.schres.2010.10.023
- 10.1192/bjp.bp.112.124883